MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

AC-73

CAS No. : 775294-71-8

MCE 站：AC-73

产品活性：AC-73 是 Cluster of Differentiation 147 (CD147) 的种特定的口服生物利用的抑制剂，可特异性破坏 CD147 的二聚化 (结合位点在 CD147 的 N 端 IgC2 域中包括 Glu64 和 Glu73)，从而抑制 CD147/ERK1/2/STAT3/MMP-2 途径，并抑制肝癌细胞的运动和侵袭。AC-73 还是一种抗增殖药，也是白血病细胞自噬的诱导剂。

研究领域：Autophagy

作用靶点：Autophagy

In Vitro: AC-73 (5-10 μM; 24 hours; SMMC-7721 and Huh-7 cells) treatment significantly decreases the migration ability of SMMC-7721 and Huh-7 cells in a dose-dependent manner and decreases the invasion of two HCC cells in a dose-dependent manner at 24 hours. AC-73 treatment reduces HCC metastases. There are no obvious effects on cell viability when two HCC cells are treated with AC-73 at a maximum concentration of 20 μM. The possible binding sites of AC-73 on CD147 included Glu64 and Glu73 in the N-terminal IgC2 domain, which two residues are located in the dimer interface of CD147.
AC-73 (5-10 μM; 24 hours; SMMC-7721 cells) treatment could significantly inhibit both MMP-2 and MMP-9 mRNA expression at the concentration of 10 μM, especially MMP-2, but no obvious effect on MMP-1, MMP-3, MMP-7, MMP-11 nor MMP-13. AC-73 could dose dependently reduce the expression of MMP-2 mRNA level and secretion of the protein level using RT-qPCR analysis and gelatin zymography experiments.
AC-73 (5-20 μM; 6 hours; SMMC-7721 cells) treatment dose-dependently suppresses the phosphorylation of ERK1/2 and STAT3.

In Vivo: AC-73 (25-50 mg/kg; for 4 weeks; Male BALB/c nu/nu mice) treatment significantly decreases the incidence of metastatic foci in nude mice. AC-73 inhibits the phosphorylation of ERK1/2 and STAT3 in a dose-dependent manner. MMP-2 is also reduced by AC-73. AC-73 could not inhibit tumor cell proliferation in vivo.

相关产品：Anti-Aging Compound Library  |  Orally Active Compound Library  |  Anti-Cancer Compound Library  |  Bioactive Compound Library Plus  |  Autophagy Compound Library  |  Rapamycin  |  MG-132  |  Cycloheximide  |  3-Methyladenine  |  LY294002  |  Olaparib  |  Actinomycin D  |  Cisplatin  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Chloroquine phosphate  |  Venetoclax  |  Paclitaxel  |  Metformin hydrochloride  |  (+)-JQ-1  |  Resatorvid  |  SB 203580  |  CHIR-99021  |  SP600125  |  Sorafenib  |  Enzalutamide  |  U0126-EtOH  |  MK-2206 dihydrochloride  |  Trametinib  |  Forskolin  |  Tamoxifen  |  Bortezomib  |  PD98059  |  Gemcitabine  |  Oxaliplatin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。